MWP
ISEE

Meridian Wealth Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Meridian Wealth Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$3K – 1398
2021
Q1 		$3K Buy
+500
New +$3.04K ﹤0.01% 923

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Meridian Wealth Partners's ISEE Position: Q2 2021 in Review

Meridian Wealth Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2021, closing a stake of 500 shares — an estimated $3K sold.

Meridian Wealth Partners first reported a position in ISEE in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 128 funds tracked by Wall St. Rank hold ISEE as of Q2 2021.

  • Meridian Wealth Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 500 IVERIC bio, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Meridian Wealth Partners first reported a position in IVERIC bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's IVERIC bio, Inc. Common Stock position peaked at $3K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.